Amy E. Juedes

Array ( [id] => 9173834 [patent_doc_number] => 20130315820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'USE OF AN ANTIBODY DIRECTED AGAINST A MEMBRANE PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/989572 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6045 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8381487 [patent_doc_number] => 20120225114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Modifying Macrophage Phenotype for Treatment of Disease' [patent_app_type] => utility [patent_app_number] => 13/309095 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11751 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13309095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220805 [patent_doc_number] => 20120135003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'ANTI-ILT7 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 13/302291 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 25125 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13302291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9190995 [patent_doc_number] => 20130330310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'EX VIVO DEVELOPMENT, EXPANSION AND IN VIVO ANALYSIS OF A NOVEL LINEAGE OF DENDRITIC CELLS' [patent_app_type] => utility [patent_app_number] => 13/885025 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9086 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239024 [patent_doc_number] => 08603815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'CD4+ CD25− T cells and Tr1-like regulatory T cells' [patent_app_type] => utility [patent_app_number] => 13/289409 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6429 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13289409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8255338 [patent_doc_number] => 20120159661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'T-Bet Compositions and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/285708 [patent_app_country] => US [patent_app_date] => 2011-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 70171 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20120159661.pdf [firstpage_image] =>[orig_patent_app_number] => 13285708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9204957 [patent_doc_number] => 20140004134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'NF-KB SIGNALING PATHWAY-MANIPULATED DENDRITIC CELLS' [patent_app_type] => utility [patent_app_number] => 13/881592 [patent_app_country] => US [patent_app_date] => 2011-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9933 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209047 [patent_doc_number] => 20120128710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Enhancement of Pathogen-Specific Memory Th17 Cell Responses' [patent_app_type] => utility [patent_app_number] => 13/282112 [patent_app_country] => US [patent_app_date] => 2011-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12955 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128710.pdf [firstpage_image] =>[orig_patent_app_number] => 13282112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8408177 [patent_doc_number] => 20120240245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'Methods and compositions for detecting and treating retinal diseases' [patent_app_type] => utility [patent_app_number] => 13/317675 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 38904 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13317675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12562410 [patent_doc_number] => 10016371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-10 [patent_title] => Antigen-specific, tolerance-inducing microparticles and uses thereof [patent_app_type] => utility [patent_app_number] => 13/880778 [patent_app_country] => US [patent_app_date] => 2011-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 6754 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197048 [patent_doc_number] => 20120121592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells' [patent_app_type] => utility [patent_app_number] => 13/269951 [patent_app_country] => US [patent_app_date] => 2011-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 12265 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121592.pdf [firstpage_image] =>[orig_patent_app_number] => 13269951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7732397 [patent_doc_number] => 20120015386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'IP-10 BASED IMMUNOLOGICAL MONITORING' [patent_app_type] => utility [patent_app_number] => 13/245521 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24031 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015386.pdf [firstpage_image] =>[orig_patent_app_number] => 13245521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754597 [patent_doc_number] => 20120027756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING ALLERGIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/242418 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20806 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027756.pdf [firstpage_image] =>[orig_patent_app_number] => 13242418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8621362 [patent_doc_number] => 08354275 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)' [patent_app_type] => utility [patent_app_number] => 13/239252 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10968 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13239252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662298 [patent_doc_number] => 20110311567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Immunogenically-Enhanced Polypeptides and Related Methods' [patent_app_type] => utility [patent_app_number] => 13/221040 [patent_app_country] => US [patent_app_date] => 2011-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 29395 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311567.pdf [firstpage_image] =>[orig_patent_app_number] => 13221040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776379 [patent_doc_number] => 20120039916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'NOVEL VACCINE ADJUVANTS BASED ON TARGETING ADJUVANTS TO ANTIBODIES DIRECTLY TO ANTIGEN-PRESENTING CELLS' [patent_app_type] => utility [patent_app_number] => 13/208993 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11319 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039916.pdf [firstpage_image] =>[orig_patent_app_number] => 13208993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11263298 [patent_doc_number] => 09487585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Antibodies against 6-sulfo-LacNac-positive human dendritic cells, and their use' [patent_app_type] => utility [patent_app_number] => 13/814512 [patent_app_country] => US [patent_app_date] => 2011-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11304 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8828726 [patent_doc_number] => 20130129771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'REGULATORY IMMUNE CELLS WITH ENHANCED TARGETED CELL DEATH EFFECT' [patent_app_type] => utility [patent_app_number] => 13/811374 [patent_app_country] => US [patent_app_date] => 2011-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 28418 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9280839 [patent_doc_number] => 20140030807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'METHOD FOR STIMULATING FOXP3+ REGULATORY T CELL EXPRESSION OF CD39' [patent_app_type] => utility [patent_app_number] => 13/811002 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14383 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499360 [patent_doc_number] => 20110262414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'HIGH AFFINITY NY-ESO T CELL RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/176090 [patent_app_country] => US [patent_app_date] => 2011-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 13590 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262414.pdf [firstpage_image] =>[orig_patent_app_number] => 13176090 [rel_patent_id] =>[rel_patent_doc_number] =>)